With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
To meet the massive unmet need in this area, Research Professor at UniSA’s Future Industries Institute, Professor Tarl Prow led the team that has created a new needle device that will revolutionise how doctors test patients for rashes and diseases.
The microbiopsy device is a small needle that can take 100 to 200 cells to test for skin cancer and other diseases avoiding the need to take a 2cm to 3cm piece of tissue which results in some scarring.
Dr Prow says the device can take skin samples much more easily than a traditional biopsy and is easy and painless to use on children.
“The innovation for this device comes from the idea of a diabetic test. We can easily take small skin samples which makes it much easier to use on children and allows us to take multiple samples over time to monitor a patient’s situation,” Prof Prow says.
“Given a standard biopsy is a significant procedure, we wanted to help make that process easier.”
The device has already proved a possible game changer in underprivileged countries with doctors from Jerusalem’s Hebrew University already taking 502 units to Africa to use in the field.
“With many parasitic diseases in Africa, where people don’t have access to a hospital, researchers at Hebrew University undertook a study in northern Ethiopia testing hundreds of children and adults using the device,” he says.
With skin cancer a more prevalent problem in Australia, doctors can spend up a significant amount of time checking a patient’s skin (including moles and pink spots) and Dr Prow and his team are working on developing cancer biomarkers, so the device can take samples and evaluate (and reveal) the results instantly.
With clinical trials (unrelated to skin cancer) in the final stages, the team is monitoring feedback with thousands of devices already sold worldwide and is patented in the US, Australia and Europe.
“We are planning to test the efficacy and safety for microbiopsy in skin cancer diagnosis that will start in early 2019 so some patients may be asked to be a part of this study. We hope to launch the approved diagnostic test in 2023,” Dr Prow says.
The Latest on: Microbiopsy
via Google News
The Latest on: Microbiopsy
- Active Voice: The Use of Microbiopsies for Study of Muscle on September 30, 2018 at 6:19 am
More recently, the microbiopsy (or fine needle aspiration) has been implemented as a minimally invasive technique using a small gauge needle for tissue sampling without the need for an incision. The f... […]
- Microbiopsy device samples skin cells for cancer without scarring on April 13, 2018 at 12:43 am
Skin cancer is the most common form of the disease, and while it might make its presence known in the form of moles or strange spots, it usually takes a biopsy to confirm whether the mark is malignant ... […]
- New needle device to revolutionise biopsies and reduce scarring on April 6, 2018 at 6:49 am
The microbiopsy device is a small needle that can take 100 to 200 cells to test for skin cancer and other diseases avoiding the need to take a 2cm to 3cm piece of tissue which results in some scarring ... […]
- MYOS RENS inks deal with University of California to study effects of Fortetropin on skeletal muscle protein synthetic rate on December 6, 2017 at 5:28 am
After 21 days, a microbiopsy will be collected from each subject to determine the fractional rate of muscle protein synthesis. The clinical study is expected to be completed in the H2 2018. Fortetropi... […]
- LEO Science & Tech Hub Announces Collaborations with MGH Wellman Center for Photomedicine to Explore Imaging Technology and Develop Microbiopsy Device on August 23, 2017 at 5:34 am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LEO Science & Tech Hub, a R&D unit of LEO Pharma dedicated to identifying, developing, and funding innovative solutions that improve the lives of people with skin di... […]
- A Microbiopsy Method for Immunohistological and Morphological Analysis: A Pilot Study on January 1, 2017 at 4:00 pm
Introduction: The fine aspiration microbiopsy is a relatively new biopsy technique, which allows muscle physiologists to sample skeletal muscle less invasively. However, the small sample size obtained ... […]
- Cancer Research at UMass Medical School. on July 27, 2016 at 5:03 am
This invention relates to an improved microbiopsy needle tip ... a pathway that plays a role in embryogenesis, angiogenesis and cancer. The method comprises contacting the FGF-responsive cell with an ... […]
- Capture of activity-induced ultrastructural changes at synapses by high-pressure freezing of brain tissue on May 28, 2014 at 5:00 pm
Figure 2: Punching and placement of slice culture onto specimen carrier. Figure 4: Fine structure of microbiopsy material and of acute slice preparations following HPF. Figure 5: Post-embedding immuno... […]
- The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions? on February 2, 2014 at 4:00 pm
First a diagnostic biopsy, ideally an imaged guided microbiopsy performed by an experienced team, is a recommended practice. On the resection specimen, the size, histological grade, location, depth, s... […]
via Bing News